The June 2025 edition of the iCARE Newsletter showcases significant progress in predicting and preventing nanomaterial toxicity effects on brain health. This issue highlights major research breakthroughs including comprehensive screening studies with C. elegans (both healthy and disease-model worms), Schmidtea mediterranea planarians, and advanced fish cell line models combining tilapia brain cells with rainbow trout systems.

The newsletter details the development of cutting-edge in vitro models, including blood-brain barrier platforms and 3D brain spheroids ("mini-brains"), alongside a comprehensive data analysis pipeline for neuro-nanotoxicity assessment. It also covers iCARE's active participation in key industry events and the Joint Regulatory Risk Assessors Summit at OECD Paris on June 19-20, 2025.

This newsletter demonstrates iCARE's ongoing commitment to advancing nanomaterial brain health safety through innovative testing methods, collaborative partnerships, and active engagement with regulatory bodies and industry stakeholders.

Read the full newsletter here.